PRIVIUM FUND MANAGEMENT (UK) LTD Neoleukin Therapeutics, Inc. Transaction History

PRIVIUM FUND MANAGEMENT (UK) LTD portfolio value:

$75,000
portfolio value

Neoleukin Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 117.2K shares 75K $0.64 117.2K